This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sukata, T. Articles by Fukushima, S. Search for Related Content PubMed PubMed Citation Articles by Sukata, T. Articles by Fukushima, S.

Organ-specific, Carcinogen-induced Increases in Cell Proliferation in p53-deficient Mice¹

Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd. [T. S., K. O., S. U., T. S., Y. O.], and First Department of Pathology, Osaka City University Medical School, Osaka 545-8558, Japan [T. S., K. O., S. U., H. W., S. Y., S. F.]

Transgenic mice with germ-line p53 alleles disrupted by gene targeting are sensitive to the development of some spontaneous tumors and have provided researchers with much information with respect to cancer. In the present study, to cast light on the organ specificity of chemically induced carcinogenesis, we evaluated carcinogen-induced cell proliferation in target organs in heterozygote p53 knockout mice (p53-deficient mice). Groups of 9- or 10-week-old wild-type(+/+) and p53-deficient mice were respectively treated with one of the following carcinogens for 4 weeks: N-butyl-N-(4-hydroxybutyl)nitrosamine (0.0075% in drinking water); dimethylnitrosamine (0.001% in drinking water); dihydroxy-di-N-propylnitrosamine (0.1% in drinking water); 1,2-dimethylhydrazine (10 mg/kg body weight s.c. injection once a week); 4-nitroquinoline 1-oxide (4-NQO, 10 mg/kg b.w. s.c. injection once a week); or 7,12-dimethylbenz(a)anthracene (25 µg/kg body weight dermal application once a week). Cell proliferation was evaluated by measuring the 5-bromo-2'-deoxyuridine labeling indices in each target organ. The p53 and p21 statuses were evaluated by comparing the expressions of p53 protein, p21^waf1/cip1 mRNA, and p21^waf1/cip1 protein between the mice. 5-Bromo-2'-deoxyuridine labeling indices of the urinary bladder and the skin were significantly increased in p53-deficient mice as compared with the wild-type(+/+) mice. In the all organs examined, carcinogen-induced p21^waf1/cip1 mRNA overexpression was detected with levels obviously lower in the p53-deficient animals. These data suggest that p53-deficient mice have an organ-specific increased sensitivity to the induction of cell proliferation in the urinary bladder and the skin. These are the same organs for which sensitivity to carcinogenesis has been reported. Because a decrease of p21^waf1/cip1 protein overexpression was also observed in the organs in which cell proliferation did not appreciably differ from the level in wild-type(+/+) mice, this decrease might have no effect on sensitivity to cell proliferation and carcinogenesis. Alternatively, it might play an important role in the cell cycle regulation of only the sensitive organs.

This article has been cited by other articles:

				S. P. Clark, T. P. Ryan, G. H. Searfoss, M. A. Davis, and S. B. Hooser Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice Toxicol Pathol, February 1, 2008; 36(2): 190 - 203. [Abstract] [Full Text] [PDF]

				M. Jaworski, S. Hailfinger, A. Buchmann, M. Hergenhahn, M. Hollstein, C. Ittrich, and M. Schwarz Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53 Carcinogenesis, October 1, 2005; 26(10): 1829 - 1834. [Abstract] [Full Text] [PDF]

				W. Salz, D. Eisenberg, J. Plescia, D. S. Garlick, R. M. Weiss, X.-R. Wu, T.-T. Sun, and D. C. Altieri A Survivin Gene Signature Predicts Aggressive Tumor Behavior Cancer Res., May 1, 2005; 65(9): 3531 - 3534. [Abstract] [Full Text] [PDF]

				F. Ide, M. Kitada, H. Sakashita, K. Kusama, K. Tanaka, and T. Ishikawa p53 Haploinsufficiency Profoundly Accelerates the Onset of Tongue Tumors in Mice Lacking the Xeroderma Pigmentosum Group A Gene Am. J. Pathol., November 1, 2003; 163(5): 1729 - 1733. [Abstract] [Full Text] [PDF]

				E. I. Salim, H. Wanibuchi, K. Morimura, M. Wei, M. Mitsuhashi, K. Yoshida, G. Endo, and S. Fukushima Carcinogenicity of dimethylarsinic acid in p53 heterozygous knockout and wild-type C57BL/6J mice Carcinogenesis, February 1, 2003; 24(2): 335 - 342. [Abstract] [Full Text] [PDF]

				K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378. [Abstract] [Full Text] [PDF]